FOLLOW US

  • facebook
  • twitter
Wed

March 18, 2026

JPMorgan

Business December 18, 2021

JPMorgan to pay $200 million to settle regulatory violations over its recordkeeping

JPMorgan agreed to pay a total of 200 million penalties to settle regulatory violations related to its widespread recordkeeping and…

By Marivic Cabural Summers

FDA Warning

Investigates March 3, 2019

FDA Warns CanaRx for Selling Unapproved and Misbranded Drugs

The U.S. Food and Drug Administration (FDA) warned CanaRx, a Canadian company, for selling “unapproved and misbranded” medicines from foreign…

By Catherine Davis

Signup for the USA Herald
exclusive Newsletter